

Tenofovir Alafenamide (Vemlidy) costs up to $1,800/month. Learn how to save with coupons, Gilead assistance programs, and other discount strategies.
If you've been prescribed Tenofovir Alafenamide (brand name Vemlidy) for chronic hepatitis B, you've probably already felt the sticker shock. The cash price for a 30-day supply ranges from $1,500 to $1,800 at most pharmacies. For a medication you may need to take indefinitely, that adds up fast.
The good news is that very few patients actually pay the full cash price. Between manufacturer programs, insurance strategies, discount cards, and patient assistance, there are real ways to significantly reduce — or even eliminate — your out-of-pocket cost. Here's everything you need to know.
Let's start with the baseline numbers:
Because there's no generic option, the savings strategies below focus on reducing the cost of brand Vemlidy.
This is the single best savings tool for patients with commercial (private) health insurance.
If you have commercial insurance and are paying anything out of pocket for Vemlidy, you should absolutely explore this program. Translation services are available in Chinese, Korean, and Vietnamese for patients who need language assistance.
If you don't have insurance or are underinsured, Gilead's Advancing Access program can provide Vemlidy at no cost.
This program has helped thousands of hepatitis B patients access their medication. If cost is your primary barrier, this should be your first call.
While discount cards typically offer the most dramatic savings on generic medications, they can sometimes reduce the price of brand-name drugs like Vemlidy. Here are the major platforms to check:
Important note: Discount cards for brand-name specialty medications like Vemlidy often offer modest savings compared to the full cash price. The manufacturer programs above will almost always be a better option if you qualify. However, discount cards can be useful as a backup or for patients who don't qualify for other programs.
Beyond Gilead's own programs, several nonprofit organizations can help connect you with financial assistance:
If you receive care at a Federally Qualified Health Center (FQHC), community health center, or qualifying hospital outpatient pharmacy, you may be able to access Vemlidy at 340B pricing, which is significantly discounted from the retail price. Ask your healthcare provider if their facility participates in the 340B Drug Pricing Program.
Many insurance plans offer lower co-pays for medications dispensed through their preferred mail-order specialty pharmacy. You may save $50-$100 or more per fill compared to retail specialty pharmacy pricing. Contact your insurance company to ask about mail-order options.
If you're choosing between insurance plans, check how each plan covers Vemlidy:
Some plans are significantly better than others for expensive specialty medications.
If the cost of Vemlidy is truly unmanageable, your doctor may be able to switch you to a more affordable alternative:
Read our full guide on alternatives to Tenofovir Alafenamide for detailed comparisons.
Tenofovir Alafenamide (Vemlidy) is an expensive medication, but the full cash price is rarely what patients actually pay. Between Gilead's co-pay assistance ($0/month for many commercially insured patients), the Advancing Access program (free for qualifying uninsured patients), discount cards, and nonprofit resources, there are multiple paths to affordability.
Don't let cost be the reason you skip your hepatitis B treatment. Explore the programs above, talk to your doctor about your options, and use Medfinder to find the best pharmacy pricing in your area.
For more information, check out our posts on why Tenofovir Alafenamide is hard to find, how to find it in stock, and side effects to watch for.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.